TRAIL Study:
Treatment of Intracranial Aneurysms With LVIS™ System
LVIS™ Coil Assist Stent
"The LVIS™/LVIS™ Jr endovascular devices are safe and effective in the treatment of ruptured and unruptured intracranial aneurysms, with acceptable complication rates, very high immediate total occlusion rates, and stable angiographic results."
- Patients
90
- Country
France
- Clinical Centers
10
- Design
Single arm prospective
- Scope
Patients ≥ 18 y.o. with an unruptured or ruptured, aneurysm, neck size ≥ 4mm or dome-to-neck ratio < 2, WFNS < 4, eligible to be treated with coils and LVIS™/LVIS™ Jr stent.
- Purpose
Assess safety and effectiveness of the LVIS™/ LVIS™ Jr devices in the treatment of wide necked intracranial aneurysms to obtain reimbursement in France.
Endpoints
Efficacy:
Anatomical stability of aneurysm treatment compared to the initial occlusion rate of the aneurysm at 6 and 18 months (assessed by Corelab)
Retreatment rate at 6 and 18 months
Safety:
Morbidity (mRS>2) rate at 6 and 18 months
Mortality rate at 6 and 18 months
Efficacy results
At 6 months:
Stent stability: 100%
Parent artery patency: 100%
Complete occlusion: 91.0%
At 18 months:
Stent stability: 100%
Parent artery patency: 100%
Complete occlusion: 92.4 %
Retreatment rate: 1.1%
Safety results
At 6 months:
Permanent morbidity (procedure-related AEs with sequelae): 4.4% (incl. 1.25% of patients with mRS>2)
At 18 months:
Morbidity & Mortality (mRS >2): 5.6%
Overall AEs with sequelae related to the stent: 2.2%
LINK TO STUDY PAGE ClinicalTrials.gov ID NCT02921711
Please refer to Instruction for Use (IFU) in the specific market/country that you are looking into:
Explore more studies
LEPI Study: Safety and Efficacy of the LVIS™ and LVIS™ Jr Devices in the Endovascular Treatment of Intracranial Aneurysms
LVIS™ Coil Assist Stent
Pivotal study: Pivotal Study of the LVIS™ (Low Profile Visualized Intraluminal Support)
LVIS™ Coil Assist Stent
Request more information
The information you provide through this form is necessary to respond to your request and may be shared with the relevant Terumo Neuro group entity or entities responsible for handling it. For more information on how we process your personal data and on your rights, please refer to our privacy policy.